Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Paradigm Biopharmaceuticals Ltd. ( (AU:PAR) ) is now available.
Paradigm Biopharmaceuticals Ltd. announced the application for the quotation of 125,000 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is expected to enhance the company’s financial positioning and provide greater liquidity to its shares, potentially attracting more investors and strengthening its market presence.
More about Paradigm Biopharmaceuticals Ltd.
Paradigm Biopharmaceuticals Ltd. is a company operating in the biopharmaceutical industry, focusing on the development and commercialization of therapies for unmet medical needs.
YTD Price Performance: 11.11%
Average Trading Volume: 8,280
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $114.8M
See more data about PAR stock on TipRanks’ Stock Analysis page.
